377 main street LLC

1325 millersport highway
suite 209
williamsville, new york 14221

NYS Entity Status
ACTIVE

NYS Filing Date
SEPTEMBER 12, 2014

NYS DOS ID#
4635594

County
ERIE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - 377 MAIN STREET LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • WD Navarre Holdings Files for Chapter 11 Protection
    Friday Sep 8, 2017

    WD Navarre Holdings LLC, the corporate parent of technology products distributor WYNIT Distribution LLC, filed for bankruptcy protection Friday.

    Source: The Wall Street Journal: Technology: What's News
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • A Main Street Independence Day
    Sunday Jul 2, 2017

    Veterans, antique cars, volleyball players—and flags everywhere.

    Source: The Wall Street Journal: Opinion
  • Caught on Camera: Short Seller Carson Block Confrontation
    Sunday Nov 5, 2017

    Short Seller Carson Block confronted a man who misrepresented himself to the founder of Muddy Waters LLC as a Wall Street Journal reporter in order to get inside information.

    Source: The Wall Street Journal: Worth It
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy VC, Deals, & Startups Feed